UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services



Document Type

Technical Report


Health Services Administration | Health Services Research | Pharmacy and Pharmaceutical Sciences


Pipeline PredictorRx™ evaluates new drugs, expected to have a significant clinical or financial impact when approved by the FDA, and compares them to current therapies.

This UMass Medical School model, entirely independent of drug company interests, goes beyond detailing pharmacy outcomes for pipeline drugs — we also examine the potential for avoiding hospitalization and other medical costs.


Pipeline PredictorRx™, drug evaluation, drug impact, pipeline drugs



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.